4//SEC Filing
Gould Stephen E 4
Accession 0001209191-23-008953
CIK 0001532346other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:53 PM ET
Size
7.5 KB
Accession
0001209191-23-008953
Insider Transaction Report
Form 4
Atreca, Inc.BCEL
Gould Stephen E
Chief Scientific Officer
Transactions
- Award
Class A Common Stock
2023-02-09+32,500→ 32,500 total - Award
Employee stock option (right to buy)
2023-02-09+130,000→ 130,000 totalExercise: $1.49Exp: 2033-02-08→ Class A Common Stock (130,000 underlying)
Footnotes (2)
- [F1]The reporting person received an award of 32,500 restricted stock units on February 9, 2023, vesting in three equal annual installments beginning on August 1, 2023. Each restricted stock unit represents a right to receive one share of Atreca Class A Common Stock upon vesting.
- [F2]1/48 of the Option vests in equal monthly installments as measured from January 1, 2023. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
Documents
Issuer
Atreca, Inc.
CIK 0001532346
Entity typeother
Related Parties
1- filerCIK 0001934498
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:53 PM ET
- Size
- 7.5 KB